Table 3.

Fatty acid composition of the placebo and DHA-rich algae oil capsules.

Fatty acid composition expressed as % the total fatty acids	DHA-rich algae oil capsule	Placebo capsule
14:0	5.90	0.07
16:0	17.0	10.7
Cis-9 16:1	0.10	0.10
18:0	0.65	3.38
Trans-9 18:1	0.18	0.00
Cis-9 18:1	6.59	25.9
Cis-11 18:1	0.20	1.34
Cis-9,trans-12 18:2	0.0	0.26
Trans-9,cis-12 18:2	0.0	0.21
20:0	0.12	0.40
20:1 n-9	0.00	0.22
22:0	0.14	0.36
24:0	0.24	0.15
n-6 fatty acids
18:2 n-6 (LA)	0.80	52.4
18:3 n-6 (ALA)	0.31	0.03
20:3 n-6	0.46	0.0
20:4 n-6 (AA)	0.48	0.0
22:4 n-6	0.13	0.0
22:5 n-6 (n-6 DPA)	19.0	0.02
n-3 fatty acids
18:3 n-3	0.0	4.49
18:4 n-3	0.36	0.01
20:4 n-3	0.96	0.0
20:5 n-3 (EPA)	1.15	0.0
22:3 n-3	0.01	0.0
22:5 n-3 (n-3 DPA)	0.59	0.0
22:6 n-3 (DHA)	44.6	0.06
Ratio or sum
∑n-3/∑n-6	2.25	0.09
DHA:n-6 DPA	2.35	3.0
∑n-6	21.2	52.9
∑n-3	47.7	4.56
∑Saturated	24.0	15.1
∑Trans fatty acids	0.18	0.47
∑Cis fatty acids	75.8	84.5

LA linoleic acid, ALA alpha-linolenic acid, AA arachidonic acid, DPA docosapentaenoic acid, EPA eicosapentaenoic acid, DHA docosahexaenoic acid.